Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AgChimedes is an Israel-based venture builder and holding company focused on food security and climate change through agbiotech, life science, data science, and AI. Rather than operating as a single-product therapeutics company, it founds and scales portfolio companies developing solutions across animal health, aquaculture, plant genetics, and crop resilience. Its disclosed portfolio includes NeoManna, Sustained Therapies, NetaGenomiX, and ReGEV Bio. The group appears positioned at the company-creation and early development stage, with programs centered on sustainable agriculture and biologically driven interventions rather than human therapeutics. For biotech analysts, AgChimedes is best viewed as an agri-life-science venture platform with multiple early-stage operating companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AgChimedes Group.